125 related articles for article (PubMed ID: 21220491)
21. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099
[TBL] [Abstract][Full Text] [Related]
22. Expression of MMP-9 and WAVE3 in colorectal cancer and its relationship to clinicopathological features.
Zhang Y; Guan XY; Dong B; Zhao M; Wu JH; Tian XY; Hao CY
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2035-44. PubMed ID: 22806308
[TBL] [Abstract][Full Text] [Related]
23. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
24. Expression of NDRG2 in Human Colorectal Cancer and its Association with Prognosis.
Chen W; Peng J; Ou Q; Wen Y; Jiang W; Deng Y; Zhao Y; Wan D; Pan Z; Fang Y
J Cancer; 2019; 10(15):3373-3380. PubMed ID: 31293640
[No Abstract] [Full Text] [Related]
25. Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast Cancer.
Kloten V; Schlensog M; Eschenbruch J; Gasthaus J; Tiedemann J; Mijnes J; Heide T; Braunschweig T; Knüchel R; Dahl E
PLoS One; 2016; 11(7):e0159073. PubMed ID: 27400234
[TBL] [Abstract][Full Text] [Related]
26. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.
Zeng ZS; Huang Y; Cohen AM; Guillem JG
J Clin Oncol; 1996 Dec; 14(12):3133-40. PubMed ID: 8955659
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of NDRG2 and NDRG3 in prostate cancer patients undergoing radical prostatectomy.
Ren GF; Tang L; Yang AQ; Jiang WW; Huang YM
Histol Histopathol; 2014 Apr; 29(4):535-42. PubMed ID: 24222185
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of NDRG2 is related to poor overall survival in patients with glioma.
Li W; Chu D; Chu X; Meng F; Wei D; Li H; Sun B
J Clin Neurosci; 2011 Nov; 18(11):1534-7. PubMed ID: 21872476
[TBL] [Abstract][Full Text] [Related]
29. NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma.
Song SP; Zhang SB; Liu R; Yao L; Hao YQ; Liao MM; Zhang YD; Li ZH
Med Oncol; 2012 Sep; 29(3):1879-85. PubMed ID: 22135002
[TBL] [Abstract][Full Text] [Related]
30. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
[TBL] [Abstract][Full Text] [Related]
31. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
32. MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.
Agosta C; Laugier J; Guyon L; Denis J; Bertherat J; Libé R; Boisson B; Sturm N; Feige JJ; Chabre O; Cherradi N
Int J Cancer; 2018 Aug; 143(4):944-957. PubMed ID: 29516499
[TBL] [Abstract][Full Text] [Related]
33. Altered expression of the PLAGL1 (ZAC1/LOT1) gene in colorectal cancer: Correlations to the clinicopathological parameters.
Kowalczyk AE; Krazinski BE; Godlewski J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Kiezun J; Wierzbicki PM; Bodek G; Sulik M; Kmiec Z
Int J Oncol; 2015 Sep; 47(3):951-62. PubMed ID: 26134521
[TBL] [Abstract][Full Text] [Related]
34. Expression and prognostic value of NDRG2 in human astrocytomas.
Li L; Wang J; Shen X; Wang L; Li X; Liu Y; Shi M; Zhao G; Deng Y
J Neurol Sci; 2011 Sep; 308(1-2):77-82. PubMed ID: 21705028
[TBL] [Abstract][Full Text] [Related]
35. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of the N-Myc Downstream-Regulated Gene 2 Promoter in Peripheral Blood Mononuclear Cells is Associated with Liver Fibrosis in Chronic Hepatitis B.
Liu XY; Fan YC; Gao S; Zhao J; Li F; Zhang J; Wang K
Tohoku J Exp Med; 2017 Feb; 241(2):155-163. PubMed ID: 28202850
[TBL] [Abstract][Full Text] [Related]
37. MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer.
Matsuyama T; Ishikawa T; Mogushi K; Yoshida T; Iida S; Uetake H; Mizushima H; Tanaka H; Sugihara K
Int J Cancer; 2010 Nov; 127(10):2292-9. PubMed ID: 20162577
[TBL] [Abstract][Full Text] [Related]
38. Expression and clinical significance of absent in melanoma 2 in colorectal cancer.
Zhang Z; Dong X; Yang X; Wan D; Sun L; Gu M; Li M; Zhu Z; Wang J; Shang Z; He S
Biomed Pharmacother; 2017 Oct; 94():843-849. PubMed ID: 28802238
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
40. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.
Imaoka H; Toiyama Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Carcinogenesis; 2015 Mar; 36(3):346-54. PubMed ID: 25568185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]